Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Details) - Schedule of options granted outstanding and exercise prices

v3.21.1
Share Capital (Details) - Schedule of options granted outstanding and exercise prices
12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Schedule of options granted outstanding and exercise prices [Abstract]  
Number of Options, outstanding at beginning | shares 1,714,039
Weighted average exercise price, outstanding at beginning | $ / shares $ 0.63
Number of Options, outstanding at ending | shares 1,814,381
Weighted average exercise price, outstanding at ending | $ / shares $ 0.58
Weighted average remaining contractual life (years), outstanding at ending 6 years 240 days
Aggregate intrinsic-value, outstanding at ending | $ $ 24,538
Number of Options, Exercisable | shares 1,209,464
Weighted average exercise price, Exercisable | $ / shares $ 0.68
Weighted average remaining contractual life (years), Exercisable 5 years 262 days
Aggregate intrinsic-value, Exercisable | $ $ 24,538
Number of Options, Granted | shares 207,500
Weighted average exercise price, Granted | $ / shares $ 0.27
Number of Options, Options forfeited | shares (107,158)
Weighted average exercise price, Options forfeited | $ / shares $ 0.88